Acitretin and treatment of the oral leucopplakias. A model to have an active molecules release
Articolo
Data di Pubblicazione:
2000
Citazione:
Acitretin and treatment of the oral leucopplakias. A model to have an active molecules release / G.M. Gaeta, F. Gombos, F. Femiano, C. Battista, P. Minghetti, L. Montanari, R.A. Saraino, G. Argenziano. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 14:6(2000), pp. 473-478.
Abstract:
Aims. The aim of this study was to investigate the effectiveness of acitretin in a new topical formulation (mucoadhesive two-layer tablets) for the treatment of oral leucoplakias. Methods. Twenty-one volunteers, 16 men, five women, with oral leucoplakia (histologically diagnosed), were included in this double-blind placebo-controlled study. Patients were randomized in three groups (A, B, C) of seven patients each. Groups A and B received tablets with different in vitro release profiles, and group C subjects (controls) received tablets without acitretin. The acitretin dose was 20 mg/day (two 10 mg tablets daily). Serum aspartate aminotransferase, alanine aminotransferase, cholesterol and triglycerides were evaluated before and after treatment. At the end of therapy the concentrations of acitretin in plasma, saliva and tissue were measured by high-performance liquid chromatography. Results. At the end of the study 71% (groups A and B) of patients showed clinical remission or marked improvement. No improvement was noted in the control subjects (group C). These results were further confirmed by histological findings. There were no significant changes in laboratory values in the three groups. The acitretin concentration in plasma and tissue ranged from 0 to 50 mg with no difference between groups A and B, and it was very high in saliva (ranging from 4.9 to 43 mg) with higher concentrations in group A than in group B (due to a longer adhesion time in group A). Patients' compliance was excellent. The results show that mucoadhesive tablets of topical acitretin are efficacious in the treatment of oral leucoplakia without systemic side-effects.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Acitretin; Mucoadhesive tablet; Oral leucoplakia; Topical treatment
Elenco autori:
G.M. Gaeta, F. Gombos, F. Femiano, C. Battista, P. Minghetti, L. Montanari, R.A. Saraino, G. Argenziano
Link alla scheda completa: